Atherosclerosis-the major underlying pathology of cardiovascular disease-is characterized by accumulation and subsequent oxidative modification of lipoproteins within the artery wall, leading to inflammatory cell infiltration and lesion formation that can over time result in arterial stenosis, ischemia, and downstream adverse events. The contribution of innate and adaptive immunity to atherosclerosis development is well established, and B cells have emerged as important modulators of both pro- and anti-inflammatory effects in atherosclerosis. Murine B cells can broadly be divided into 2 subsets: (1) B-2 cells, which are bone marrow derived and include conventional follicular and marginal zone B cells, and (2) B-1 cells, which are largely fetal liver derived and persist in adults through self-renewal. B-cell subsets are developmentally, functionally, and phenotypically distinct with unique subset-specific contributions to atherosclerosis development. Mechanisms whereby B cells regulate vascular inflammation and atherosclerosis will be discussed with a particular emphasis on B-1 cells. B-1 cells have a protective role in atherosclerosis that is mediated in large part by IgM antibody production. Accumulating evidence over the last several years has pointed to a previously underappreciated heterogeneity in B-1 cell populations, which may have important implications for understanding atherosclerosis development and potential targeted therapeutic approaches. This heterogeneity within atheroprotective innate B-cell subsets will be highlighted.

中文翻译：

---

2019 年罗素罗斯血管生物学纪念讲座：B 淋巴细胞介导的动脉粥样硬化保护性免疫。

动脉粥样硬化是心血管疾病的主要潜在病理，其特征在于脂蛋白在动脉壁内的积累和随后的氧化修饰，导致炎症细胞浸润和病变形成，随着时间的推移会导致动脉狭窄、缺血和下游不良事件。先天免疫和适应性免疫对动脉粥样硬化发展的贡献已得到公认，并且 B 细胞已成为动脉粥样硬化中促炎和抗炎作用的重要调节剂。鼠 B 细胞大致可分为 2 个亚群：(1) B-2 细胞，它们是骨髓来​​源的，包括传统的滤泡和边缘区 B 细胞，以及 (2) B-1 细胞，主要是胎肝来源和通过自我更新在成人中持续存在。B 细胞亚群在发育过程中，在功能上和表型上不同，对动脉粥样硬化的发展具有独特的亚群特异性贡献。将讨论 B 细胞调节血管炎症和动脉粥样硬化的机制，特别强调 B-1 细胞。B-1 细胞在很大程度上由 IgM 抗体产生介导的动脉粥样硬化中具有保护作用。过去几年积累的证据表明，B-1 细胞群中存在先前未被充分认识的异质性，这可能对了解动脉粥样硬化的发展和潜在的靶向治疗方法具有重要意义。动脉粥样硬化先天 B 细胞亚群中的这种异质性将被强调。将讨论 B 细胞调节血管炎症和动脉粥样硬化的机制，特别强调 B-1 细胞。B-1 细胞在很大程度上由 IgM 抗体产生介导的动脉粥样硬化中具有保护作用。过去几年积累的证据表明，B-1 细胞群中存在先前未被充分认识的异质性，这可能对了解动脉粥样硬化的发展和潜在的靶向治疗方法具有重要意义。动脉粥样硬化先天 B 细胞亚群中的这种异质性将被强调。将讨论 B 细胞调节血管炎症和动脉粥样硬化的机制，特别强调 B-1 细胞。B-1 细胞在很大程度上由 IgM 抗体产生介导的动脉粥样硬化中具有保护作用。过去几年积累的证据表明，B-1 细胞群中存在先前未被充分认识的异质性，这可能对了解动脉粥样硬化的发展和潜在的靶向治疗方法具有重要意义。动脉粥样硬化先天 B 细胞亚群中的这种异质性将被强调。过去几年积累的证据表明，B-1 细胞群中存在先前未被充分认识的异质性，这可能对了解动脉粥样硬化的发展和潜在的靶向治疗方法具有重要意义。动脉粥样硬化先天 B 细胞亚群中的这种异质性将被强调。过去几年积累的证据表明，B-1 细胞群中存在先前未被充分认识的异质性，这可能对了解动脉粥样硬化的发展和潜在的靶向治疗方法具有重要意义。动脉粥样硬化先天 B 细胞亚群中的这种异质性将被强调。